Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye

Launched by DEPARTMENT OF MEDICAL SERVICES MINISTRY OF PUBLIC HEALTH OF THAILAND · Mar 5, 2025

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age more than or equal 18 year-old
• • Ocular Surface Disease Index (OSDI) more than or equal 23
• • Oxford grading scale more than or equal 2 (both eye)
• • Fluorescein tear break-up time less than 7 seconds (both eyes)
• • Willing to being a subject in research.
• Exclusion Criteria:
• • Diagnosed with other eye diseases that require medication which is not used to treat dry eye, such as Glaucoma
• • History of Ocular surgery in previous 3 months or Refractive surgery in previous 6 months
• • History of ocular trauma, infection, ocular inflammation which is not involved with dry eye in previous 3 months
• • Wear contact lenses
• • Allergic to Sodium hyaluronate
• • Pregnant or lactation period
• • Diagnosed with physical diseases that affect the eyes and cannot yet be controlled, such as uncontrolled DM (Diabetes Mellitus), active autoimmune disease, and systemic neuropathy induced neurotrophic keratopathy. - Continuous use of medications for diseases such as Retinoic acid derivatives, Antihistamines, Cholinergic agents, and Antipsychotic agents which can lead to chronic dry eye
• • Incompleted data.